NanoViricides, Inc. NEW (NNVC): Price and Financial Metrics
GET POWR RATINGS... FREE!
NNVC Stock Price Chart Interactive Chart >
NNVC Price/Volume Stats
| Current price | $1.43 | 52-week high | $3.88 |
| Prev. close | $1.39 | 52-week low | $1.04 |
| Day low | $1.36 | Volume | 10,828 |
| Day high | $1.44 | Avg. volume | 20,343 |
| 50-day MA | $1.40 | Dividend yield | N/A |
| 200-day MA | $1.80 | Market Cap | 16.55M |
NanoViricides, Inc. NEW (NNVC) Company Bio
NanoViricides, Inc. is a biopharmaceutical company. The Company researches treatments for viruses such as AIDS/HIV, Hepatitis C, influenza, and Asian bird flu.
Latest NNVC News From Around the Web
Below are the latest news stories about NANOVIRICIDES INC that investors may wish to consider to help them evaluate NNVC as an investment opportunity.
NanoViricides, Inc. to Present at the Biotech Showcase(TM) 2023 Conference in San Fransisco on January 9th at 10:30am PTNanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), announces that the Company's President, Dr. Anil Diwan, will be presenting a talk in person at the Biotech Showcase™ 2023 Conference in San Fransisco on Monday, January 9th at 10:30pm PT. |
NanoViricides, Inc. to Present at the RHK Capital Disruptive Growth Conference in New York City on December 6th at 1:20pm ETNanoViricides, Inc. (NYSE Amer. NNVC) (the "Company"), announces that the Company's President, Dr. Anil Diwan, will be presenting a talk at the RHK Capital Disruptive Growth Conference in New York City on December 6th at 1:20pm ET. |
NanoViricides, Inc. Has Filed its Quarterly Report: Coronavirus Drug NV-CoV-2 IND StageNanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal first quarter ending September 30, 2022 with the Securities and Exchange Commission (SEC) on Monday, November 14, 2022. |
7 Speculative Penny Stocks Under $3 That Deserve Your Attention in Nov.Speculative penny stocks don't look as volatile now that volatility is unavoidable. |
This Company Is Looking For A Monkeypox Drug As City Investigates DeathsBy David Willey, Benzinga |
NNVC Price Returns
| 1-mo | 6.72% |
| 3-mo | -13.60% |
| 6-mo | -53.57% |
| 1-year | -40.91% |
| 3-year | -79.42% |
| 5-year | -92.92% |
| YTD | 28.83% |
| 2022 | -70.16% |
| 2021 | 29.62% |
| 2020 | 14.34% |
| 2019 | -37.25% |
| 2018 | -77.27% |
Loading social stream, please wait...